Literature DB >> 6434394

The etiology of pigment gallstones.

J D Ostrow.   

Abstract

Pigment gallstones are of two major types, black and earthy brown, each consisting of calcium salts of bilirubin and other anions, along with an unmeasured residue that is largely mucin glycoproteins. Studies in model systems indicate that the small proportion of unconjugated bilirubin in bile is solubilized by bile salts and that the ionized bilirubin is more soluble than the protonated diacid. Solubility is decreased by added lecithin but is unaffected by cholesterol. At the pH of bile, unconjugated bilirubin exists mainly as a monoanion with sufficient solubility in mixed micelles not to precipitate, were it not for the presence of calcium, which forms highly insoluble salts with unconjugated bilirubin anions. Supersaturation of bile with calcium bilirubinates is inhibited by bile salts, which bind calcium, reducing the activity of free calcium ions. When supersaturation occurs, usually due to increased concentrations of bilirubinate anion, nucleation may be initiated by binding of calcium bilirubinate to mucin glycoproteins in bile. In earthy brown stones, which form mainly in the bile ducts, the pigment is mostly calcium bilirubinate, combined with calcium palmitate. These components form due to hydrolysis, by enzymes in infecting bacteria, of conjugated bilirubin and lecithin, respectively. In black stones, which form mainly in the gallbladder, the pigment is mostly a highly cross-linked network polymer of bilirubin, which is insoluble in all solvents. Concomitant polymerization and oxidation of calcium bilirubinate probably occur in the solid state, after precipitation of the pigment due to hydrolysis of conjugated bilirubin by endogenous beta-glucuronidase from the biliary tract and/or liver.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434394     DOI: 10.1002/hep.1840040840

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Effect of binding of ionised calcium on the in vitro nucleation of cholesterol and calcium bilirubinate in human gall bladder bile.

Authors:  S Gallinger; P R Harvey; C N Petrunka; S M Strasberg
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

Review 2.  Stone analysis.

Authors:  R Asper
Journal:  Urol Res       Date:  1990

Review 3.  Medical aspects of gallstones--1985: sixty years on.

Authors:  R H Dowling; D Gleeson
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

Review 4.  Surgical treatments for patients with recurrent bile duct stones and Oddis sphincter laxity.

Authors:  Boxuan Zhou; Jinxiong Hu; Yuesi Zhong
Journal:  Intractable Rare Dis Res       Date:  2017-08

5.  The role of bacteria in gallbladder and common duct stone formation.

Authors:  H S Kaufman; T H Magnuson; K D Lillemoe; P Frasca; H A Pitt
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

6.  Gallstone Classification in Western Countries.

Authors:  Andrea Cariati
Journal:  Indian J Surg       Date:  2013-01-29       Impact factor: 0.656

7.  Pigment gallstones form as a composite of bacterial microcolonies and pigment solids.

Authors:  L Stewart; A L Smith; C A Pellegrini; R W Motson; L W Way
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

8.  Biliary sludge and pigment stone formation in bile duct-ligated guinea pigs.

Authors:  C Y Chen; S C Shiesh; X Z Lin
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

9.  High rate of complicated idiopathic gallstone disease in pediatric patients of a North American tertiary care center.

Authors:  Denise Herzog; Guylaine Bouchard
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

10.  The pathophysiological characteristics of bile from patients with gallstones: the role of prostaglandins and mucin in gallstone formation.

Authors:  T Inoue; Y Mishima
Journal:  Jpn J Surg       Date:  1990-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.